Ethema Health Corp (GRST)

[Bubae]

The company does a good job cultivating and promoting the EBITDA number. When the Leonite June note defaults they can use that 24% to also help boost the EBITDA number. The use of that number is a bit of con. They never talk about revenue or real earnings for a reason. statements like "...growth will become our sole objective after repaying the debt...." are misleading as well. After repaying the debt?!? What year might that be? LOL


EBITDA = Net Income + Taxes + Interest Expense + Depreciation & Amortization

For the quarterly period ended March 31, 2022
https://sec.report/Document/0001903596-22-000301/
Interest expense $ 80,768

For the quarterly period ended June 30, 2022
https://sec.report/Document/0001903596-22-000529/
Interest expense $122,848

For the quarterly period ended September 30, 2022
https://www.otcmarkets.com/filing/html?id=16200583&guid=wEG-knVR-IG9dth
Interest expense $163,561


Ethema Posts Strong 3rd Quarter Results and SEC Qualifies the Regulation A Form 1A Filing
November 29, 2022 08:00 ET | Source: Ethema Health Corporation
https://www.globenewswire.com/en/news-release/2022/11/29/2563968/0/en/Ethema-Posts-Strong-3rd-Quarter-Results-and-SEC-Qualifies-the-Regulation-A-Form-1A-Filing.html

The Company’s ARIA subsidiary continued its growth and had a $712,839.00 EBITDA for the first nine months of the year.The Company’s wholly owned subsidiary, PB Billing LLC, which started operating in May 2022, had an EBITDA of $34,579.00 for the first 9 months of the year. Companywide EBITDA for the first nine months of the year was $898,920.00.

Mr. Shawn Leon, Company CEO, reported, “We had set a goal at the beginning of the year for our ARIA subsidiary to produce an EBITDA of $1,000,000 for calendar 2022. It looks like we are on track to make that goal and are very proud of our many associates and team members for helping us get there.

...We expect to substantially grow the EBITDA in 2023 as growth will become our sole objective after repaying the debt.”